Latest Market Research Report 2025

  The global  ophthalmic drugs market  size is expected to reach USD 62.08 billion by 2030, garnering a CAGR of 8.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising awareness about ophthalmic disorders and the surge in demand for ophthalmic drugs are the factors propelling the market growth. Moreover, an increase in the prevalence of eye diseases such as age-related macular degeneration, cataract, dry eye, diabetic retinopathy, glaucoma, and others are anticipated to boost the demand for ophthalmic drugs.   According to BrightFocus Foundation in 2021, it is estimated that over 3 million Americans are living with glaucoma, and, among them over 2.7 million patients were affected by the most common type of glaucoma i.e. open-angle glaucoma. Moreover, 3.3 million people are affected by blindness and low vision in the U.S. Some of the major risk factors for glaucoma and blindness are, higher age, family history, thin cornea, and h...

  Ophthalmic Drugs Industry Overview The global ophthalmic drugs market size was valued at USD 36.7 billion in 2020. It is expected to expand at a compound annual growth rate (CAGR) of 6.4% from 2021 to 2028.   Increasing awareness regarding eye-related diseases and rising advancements in technologies are some of the major factors expected to accelerate market growth. The rising prevalence of eye-related disorders, such as diabetic retinopathy, macular degeneration, and presbyopia is expected to boost market growth over the forecast period. For instance, according to the National Eye Institute, the projected number of U.S. citizens suffering from AMD is estimated to increase from 2.07 million in 2030 to 5.44 million in 2050. In the case of diabetic retinopathy in the U.S., the total number of cases is projected to be 14.6 million in 2050. Gather more insights about the market drivers, restrains and growth of the Global Ophthalmic Drugs Market In addition, op...